Elicio Therapeutics, Inc.ELTXNASDAQ
LOADING
|||
Year-over-year earnings per share growth rate
| Period | Value |
|---|---|
| Q3 2025 | 9.09% |
| Q2 2025 | 24.14% |
| Q1 2025 | 24.35% |
| Q4 2024 | 17.27% |
| Q3 2024 | -117.19% |
| Q2 2024 | 44.35% |
| Q1 2024 | -23.66% |
| Q4 2023 | 64.37% |
| Q3 2023 | -6.97% |
| Q2 2023 | 2.79% |
| Q1 2023 | -16.74% |
| Q4 2022 | 5.29% |
| Q3 2022 | 4.22% |
| Q2 2022 | 50.11% |
| Q1 2022 | -195.57% |
| Q4 2021 | 194.49% |
| Q3 2021 | 8.52% |
| Q2 2021 | -1123.40% |
| Q1 2021 | 87.86% |
| Q4 2020 | -63.29% |
| Q3 2020 | 12.87% |
| Q2 2020 | -518.18% |
| Q1 2020 | 91.90% |
| Q4 2019 | 0.00% |